Bøger af World Health Organization

The monographs in this volume summarize the safety data on 10 pesticides that could leave residues in food commodities. These pesticides are aminocyclopyrachlor, cyflumetofen, dichlobenil, flufenoxuron, imazamox, mesotrione, metrafenone, myclobutanil, pymetrozine and triforine. The data summarized in the toxicological monographs served as the basis for the acceptable daily intakes and acute reference doses that were established by the Meeting.This volume and previous volumes of JMPR toxicological evaluations, many of which were published in the FAO Plant Production and Protection Paper series, contain information that is useful to companies that produce pesticides, government regulatory officers, industrial testing laboratories, toxicological laboratories and universities.

As a new member of WHO Family of International Classifications ICF describes how people live with their health condition. ICF is a classification of health and health related domains that describe body functions and structures activities and participati

A state-of-the-art review of research findings that contribute to an understanding of hypertension and the best measures for its prevention and control, whether in individual patients or entire populations. Noting that elevated blood pressure is a massive health problem in almost every country, the report argues that programs for hypertension control should be an integral part of all national health care systems. With this goal in mind, the report aims to help policy makers appreciate the significance and complexities of hypertension, understand the options available for control and then select the most appropriate mix of interventions. Details range from recommended procedures for obtaining an accurate assessment of blood pressure through advice on the best drugs for first-line treatment of hypertensive patients to a discussion of ways to educate populations about relevant lifestyle changes Throughout the report, population-based and individual approaches are presented as complementary, synergistic strategies for hypertension control. To assist physicians as well as policy makers, the report includes abundant recommendations based on the best scientific evidence for the management of different patient groups. A section on the clinical assessment of the hypertensive patient explains the components of a coherent step-wise diagnostic process involving history taking physical examination and laboratory investigation. Included are an assessment of the most suitable drugs for first-line treatment and guidelines for developing management plans for mild hypertension, moderate and severe hypertension, resistant hypertension and hypertensive emergencies. In view of the need to assure that scarce resources are invested wisely, the report also discusses and compares the cost-effectiveness of different management strategies.

A didactic guide to all health-related measures needed to prepare for natural disasters, reduce their immediate impact, and facilitate recovery. Noting that all natural disasters share several features, the book aims to provide a framework that administrators can rely on when planning and managing the health sector's response. Details range from a list of eight misconceptions that may cause authorities to take inappropriate action, through a discussion of the sensitive issues surrounding inappropriate drug and food donations, to a distinction between responsibilities best handled by the affected country and those requiring international aid. Throughout the book, recent experiences from the Americas are used to illustrate both the impact of specific types of disaster and opportunities for mitigating their effects.

Worldwide, the application of information and communication technologies to support national health-care services is rapidly expanding and increasingly important. This is especially so at a time when all health systems face stringent economic challenges and greater demands to provide more and better care, especially to those most in need.

From guidance on pesticide legislation to a pesticide registration toolkit, this compendium provides a brief description of all the technical documents, manuals, databases and other resources for pesticide management developed by FAO and WHO.

Reviews the status of the microbiological safety of lipid-based ready-to-use foods (RUFs) and provides guidance to producers on the general approach and requirements for manufacturing RUFs that are safe for their intended use.

PLEASE NOTE: Text has been accidentally deleted frompage 54 of this book. Please refer to the corrigenda (PDF file) posted on the Stylus Publishing web site or email stylusinfo@styluspub.com for an updated, printable page. ****When not purchasing directly from the official sales agents of the WHO, especially at online bookshops, please note that there have been issues with counterfeited copies. Buy only from known sellers and if there are quality issues, please contact the seller for a refund.***** Soft Tissue and Bone Tumours is the third volume in the 5th edition ofthe WHO series on the classification of human tumors. This series (also knownas the WHO Blue Books) is regarded as the gold standard for the diagnosis oftumors and comprises a unique synthesis of histopathological diagnosis with digital and molecular pathology. These authoritative and concise referencebooks provide indispensable international standards for anyone involved in thecare of patients with cancer or in cancer research, underpinning individualpatient treatment as well as research into all aspects of cancer causation, prevention, therapy, and education. This volume will be of particular interest to pathologists, oncologists, surgeons, and epidemiologists who manage or research soft tissue and bonetumors. Sections are included on all recognized neoplasms of the soft tissueand bone, as well as on genetic tumor syndromes affecting these sites. Sincethe previous edition, there have been changes based on recent molecular andgenetic information, with impact on clinical practice.

This technical brief on the nexus between Water Sanitation and Hygiene (WASH) and antimicrobial resistance (AMR) presents six action areas for coordinated multi-sectoral action, for consideration and refinement in each country context.

Synthesizes the current scientific literature concerning the transmission of antimicrobial-resistant bacteria, antimicrobial residues and antimicrobial resistance genes from environmental sources (e.g. contaminated water, soil, fertilizers, processing and transportation facilities) to foods and feeds of plant and aquatic animal origin.

The meeting reported on the current knowledge of hazards associated with feed, including insects, former food and food processing by-products and biofuel by-products. It also discussed the use of this information to identify knowledge gaps and prioritize future work for risk analysis purposes.

Reviews the causes of veterinary drug carryover in animal feed and the transfer from feed to food, as well as known risks to human health and international trade, and suggests appropriate risk management strategies.

Provides guidance on safe water use when preparing fresh produce and fish. The report is also a guide for water risk management. Water is a major input in food, from primary production through all stages in the food value chain to consumption.

Reviews pesticide use patterns and good agricultural practices, data on the chemistry and composition of pesticides, and methods of analysis for pesticide residues and recommended maximum residue levels. The report also contains information on acceptable daily intakes and acute reference doses of pesticides for humans.

This report uses a comprehensive framework for studying health risks that was developed for the World Health Report 2002, which presented estimates for the year 2000. The report provides an update for the year 2004 for 24 global risk factors. It uses updated information from WHO programs and scientific studies for both exposure data and the causal associations of risk exposure to disease and injury outcomes. The burden of disease attributable to risk factors is measured in terms of lost years of healthy life using the metric of the disability-adjusted life year (DALY). The DALY combines years of life lost due to premature death with years of healthy life lost due to illness and disability. Health risks are in transition: populations are ageing owing to successes against infectious diseases; at the same time, patterns of physical activity and food, alcohol and tobacco consumption are changing. Low- and middle-income countries now face a double burden of increasing chronic, noncommunicable conditions, as well as the communicable diseases that traditionally affect the poor.

This item is sold only in sets of 50. This WHO booklet includes the Model International Certificate of Vaccination or Prophylaxis contained in Annex 6 of the International Health Regulations (2005). The Certificate is used for recording vaccinations or prophylaxis in accordance with the IHR (2005), including vaccination or revaccination against yellow fever. Additional pages in the booklet have space for recording other vaccinations. (Please note the World Health Organization intends for these ICV sets to be sold to professional health organizations and companies that provide vaccination services. If you are an individual in need of one ICV booklet, please contact your local health provider, who should be able to give you one free of charge.)

WHO in collaboration with the International Commission for Radiologic Education (ICRE) of the International Society of Radiology (ISR) and the other members of the Global Steering Group for Education and Training in Diagnostic Imaging is creating a series

This report considers what can, and should be done to comfort patients suffering from distressing symptoms of advanced cancer. The book draws together the evidence and arguments needed to define clear lines of action, whether by the medical or nursing professions, or by national legislation.

In response to the growing concern about equity issues and their implications for overall development, WHO established the Commission on Social Determinants of Health (CSDH) in 2005, which focused on the "social justice" or human rights arguments for health investments. CSDH investigated the factors involved in the so-called "social gradient in health", which refers to the large observable differences in health outcomes within and between countries that are determined by avoidable inequalities in the access to resources and power. CSDH aimed to further investigate the causes of health inequities, with a deliberate detachment from economic considerations, and provide advice on how to tackle them effectively. CSDH also reviewed evidence for action on a wider scope of interventions than CMH, many of which require intersectoral collaboration or advocacy. With CMH and CSDH having adopted different but perhaps complementary standpoints, it soon became clear that greater synergies had to be forged between the two. This WHO resource book on the economics of social determinants of health and health inequalities seeks to begin to build a bridge between the two approaches by explaining, illustrating and discussing the economic arguments that could (and could not) be put forth to support the case for investing in the social determinants of health on average and in the reduction in socially determined health inequalities. The resource book has two main objectives: * to provide an overview and introduction into how economists would approach the assessment of the economic motivation to invest in the social determinants of health and socially determined health inequities, including what the major challenges are in this assessment; * to illustrate the extent to which an economic argument can be made in favor of investment in three major social determinants of health areas: education, social protection, and urban development and infrastructure.